Перейти к основной навигации
Перейти к поиску
Перейти к основному содержанию
Сортировать по:
INIS
antibiotics
100%
kazakhstan
83%
policy
39%
asia
34%
surveillance
25%
reviews
25%
populations
21%
humans
21%
hospitals
20%
covid-19
19%
guidelines
16%
kyrgyzstan
16%
tajikistan
15%
data
14%
implementation
14%
doses
13%
surveys
12%
uzbekistan
12%
evaluation
10%
attitudes
10%
optimization
10%
public health
10%
modeling
10%
time-series analysis
9%
patients
8%
income
8%
diseases
7%
monitoring
7%
communities
6%
resources
6%
sales
5%
levels
5%
research programs
5%
expenditures
5%
influenza
5%
growth
5%
coronaviruses
5%
allocations
5%
consumption rates
5%
russian federation
5%
Keyphrases
Kazakhstan
50%
Central Asia
25%
Antibiotic Consumption
23%
Antimicrobial Resistance
21%
Evidence-based Policy
21%
Antibiotic Stewardship
21%
Evidence-based Practice
21%
Consumption Trends
18%
Kyrgyzstan
15%
Tajikistan
14%
Antiprotozoal Agents
10%
Antiprotozoal
10%
Antifungal Agents
10%
Population Rates
10%
Antibiotic (antimicrobial) Resistance
10%
Social Determinants of Health (SDoH)
10%
Health Consumption
10%
Human Healthcare
10%
General Practitioners
10%
Antibiotic Prescribing
10%
Uzbekistan
10%
Prescribing Behavior
10%
Antibiotic Resistance
10%
Defined Daily Dose
9%
Historical Trends
7%
Hospital Sector
7%
Series Analysis
7%
Antibiotics
6%
Average Annual Percent Change
6%
Public Health Policy
5%
Collaborative Research
5%
Antiherpes
5%
Policy Allocation
5%
Anti-influenza Agents
5%
Predictive Modeling
5%
Community Sector
5%
Hepatitis B Surface Antigen (HBsAg)
5%
Resource Allocation
5%
Public Health Resources
5%
Coronavirus disease-19 Pandemic
5%
Annual Growth
5%
Low-middle Income Countries
5%
Clinical Practice Guidelines
5%
Antimicrobial Stewardship Program
5%